Veterinary Medicines

Vanguard Lepto-ci

Authorised
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
Download as PDF

Product identification

Medicine name:
Vanguard Lepto-ci
Active substance:
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Canicola, strain C51, Inactivated
    40.00
    unit(s)
    /
    1.00
    millilitre(s)
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
    40.00
    unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 100vials of 1 ml.
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 25vials of 1 ml.
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 10vials of 1 ml.
  • The vaccine is filled in 1 dose vials glass type I (Ph.Eur.). Pack contains 1vial of 1 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/085/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download